Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the …

BM Demaerschalk, DO Kleindorfer, OM Adeoye… - Stroke, 2016 - Am Heart Assoc
Purpose—To critically review and evaluate the science behind individual eligibility criteria
(indication/inclusion and contraindications/exclusion criteria) for intravenous recombinant …

Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes

MJ Reeves, CD Bushnell, G Howard… - The Lancet …, 2008 - thelancet.com
Stroke has a greater effect on women than men because women have more events and are
less likely to recover. Age-specific stroke rates are higher in men, but, because of their …

[图书][B] Planning health promotion programs: an intervention mapping approach

LKB Eldredge, CM Markham, RAC Ruiter… - 2016 - books.google.com
The Intervention Mapping bible, updated with new theory, trends, and cases Planning
Health Promotion Programs is the" bible" of the field, guiding students and practitioners …

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)

W Hacke, M Kaste, C Fieschi, R Von Kummer… - The Lancet, 1998 - thelancet.com
Background Thrombolysis for acute ischaemic stroke has been investigated in several
clinical trials, with variable results. We have assessed the safety and efficacy of intravenous …

Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on …

DK Moser, LP Kimble, MJ Alberts, A Alonzo, JB Croft… - Circulation, 2006 - Am Heart Assoc
Patient delay in seeking treatment for acute coronary syndrome and stroke symptoms is the
major factor limiting delivery of definitive treatment in these conditions. Despite decades of …

The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument

AM Nor, J Davis, B Sen, D Shipsey, SJ Louw… - The Lancet …, 2005 - thelancet.com
Background In patients with acute stroke, rapid intervention is crucial to maximise early
treatment benefits. Stroke patients commonly have their first contact with medical staff in the …

Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis

RL Williams-Karnesky, US Sandau… - The Journal of …, 2013 - Am Soc Clin Investig
Epigenetic modifications, including changes in DNA methylation, lead to altered gene
expression and thus may underlie epileptogenesis via induction of permanent changes in …

Delay in presentation and evaluation for acute stroke: Stroke Time Registry for Outcomes Knowledge and Epidemiology (STROKE)

CR Lacy, DC Suh, M Bueno, JB Kostis - Stroke, 2001 - Am Heart Assoc
Background and Purpose—Early treatment is a critical determinant of successful
intervention in acute stroke. The study was designed to find current patterns of stroke care by …

Factors Associated With Delayed Admission to Hospital and In-Hospital Delays> in Acute Stroke and TIA: A Prospective, Multicenter Study

P Wester, J Rådberg, B Lundgren, M Peltonen - Stroke, 1999 - Am Heart Assoc
Background and Purpose—Early admission to hospital followed by correct diagnosis with
minimum delay is a prerequisite for successful intervention in acute stroke. This study aimed …

A systematic review of barriers to delivery of thrombolysis for acute stroke

J Kwan, P Hand, P Sandercock - Age and ageing, 2004 - academic.oup.com
Background and purpose: barriers within the patient pathway can prevent early
administration of thrombolytic therapy in patients admitted with acute stroke. This systematic …